Core Insights - Adtalem Global Education Inc. (ATGE) reported strong third-quarter fiscal 2025 results, with adjusted earnings and revenues exceeding expectations and showing year-over-year growth [1][3] - The company's performance was driven by increased enrollment and higher tuition rates across all reportable segments, supported by strategic investments to enhance student experience [1][2] Earnings & Revenue Discussion - Adjusted earnings per share (EPS) reached $1.92, surpassing the Zacks Consensus Estimate of $1.63 by 17.8%, and increased from $1.50 in the prior year [3] - Revenues totaled $466.1 million, exceeding the consensus mark of $444 million by 4.9% and growing 12.9% year over year [3] - Total student enrollment rose 9.8% year over year to 94,223 students, compared to a predicted enrollment of 88,056 [3] Operating Performance - Adjusted operating income increased 17.4% year over year to $105.4 million, with an adjusted operating margin expanding 80 basis points to 22.6% [4] - Adjusted EBITDA was $127.8 million, up 19.3% from the prior year, with an adjusted EBITDA margin expanding 150 basis points to 27.4% [4] Segment Performance - Chamberlain segment revenues increased 13.1% year over year to $192.6 million, with total student enrollment rising 6.8% to 40,564 students [5] - Walden segment generated revenues of $178.4 million, up 18.5% year over year, with total student enrollment increasing 13.5% to 48,526 students [7] - Medical and Veterinary segment revenues increased 3.6% to $95 million, with total student enrollment slightly up by 1.2% to 5,133 students [8] Liquidity & Cash Flow - As of March 31, 2025, Adtalem had cash and cash equivalents of $219 million, with long-term debt reduced to $552.2 million from $648.7 million at the end of fiscal 2024 [10] - For the first nine months of fiscal 2025, cash provided by operating activities totaled $273.8 million, up from $227.1 million in the prior year [11] Fiscal 2025 Guidance - Adtalem raised its fiscal 2025 revenue guidance to a range of $1,760-$1,775 million, up from the previous estimate of $1,730-$1,760 million, and adjusted earnings guidance to $6.40-$6.60 per share from $6.10-$6.30 [12]
Adtalem Stock Gains on Q3 Earnings & Revenue Beat, FY25 View Up